Label updates reflect growing body of real-world evidence and regulatory confidence in the safety profile of the class of CD19- and BCMA-directed autologous CAR T cell therapies, reinforcing efforts to increase equitable access
The initiation of a second Phase 3 clinical trial for bomedemstat demonstrates company’s commitment to advancing research in myeloproliferative neoplasms (MPNs)
The integrated company delivers a broad portfolio of over 30,000 lab products across microscopy, histology, and other research areas
Tornado will enhance Bruker’s biopharma PAT portfolio with its well-established products
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023
Acuitas Therapeutics' LNP technology will support Bayer’s in vivo gene editing and protein replacement programs with the goal of specifically delivering RNA payloads to the desired target organ, the liver.
Strategies aimed at solving the current overdose epidemic must go beyond the identification of risk
Subscribe To Our Newsletter & Stay Updated
